(Q34358206)

1 August 2017

1 reference

title

Vaccine adjuvants: current state and future trends (English)

1 reference

1 August 2017

1 reference

Nikolai Petrovsky

1

0 references

author name string

Julio César Aguilar

series ordinal

2

1 reference

1 August 2017

publication date

1 October 2004

1 reference

Immunology & Cell Biology

1 August 2017

published in

1 reference

1 August 2017

volume

82

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

488-496

1 reference

Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Selection of potent immunological adjuvants for vaccine construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Protection against vaginal SIV transmission with microencapsulated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Antigen sampling across epithelial barriers and induction of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Adjuvants: current status, clinical perspectives and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Natural and synthetic trehalose diesters as immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Response to influenza vaccine in adjuvant 65-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

21 January 2018

New aspects of liposomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Use of liposomes as biodegradable and harmless adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

The adjuvanticity of Algammulin, a new vaccine adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

The iscom structure as an immune-enhancing moiety: experience with viral systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

The importance of mucosal immunology to problems in human reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

New strategies for using mucosal vaccination to achieve more effective immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

The mucosal immune system: from fundamental concepts to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Epithelial M cells: gateways for mucosal infection and immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Potential of particulate carriers for the mucosal delivery of DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Advances in cancer vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Antitumour immune response and cancer vaccination: the critical role of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

Liposomes as immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01272.X

10.1111/J.0818-9641.2004.01272.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference